Jyong Biotech Ltd. Ordinary Shares MENS · SEC Filings

website

Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, a...

Price1.85

Market Cap140.65 M

Float28.06 M

CountryTW

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 14, 2026

NT 20-F

Form NT 20-F - Notification of inability to timely file Form 20-F

Apr 29, 2026

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B4

SHARE RESALE REGISTRATION | Shares amount: 2,666,667 | Share price: $7.50 | Offering amount: $20,000,000

Jun 18, 2025

Registrations

TYPE

HEADLINE

FILED AT

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Jun 12, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Jun 6, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Apr 23, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 27, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 26, 2025

F-1/A

SHARE RESALE REGISTRATION | Shares amount: 2,666,667 | Share price: $7.50 | Offering amount: $20,000,000

Mar 11, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D

Perfect Mind Co., Ltd (Filed by)

Apr 24, 2026

ZHANG WEI (VIVI) (Reporting)

Apr 14, 2026

KUO FU-FENG (Reporting)

Apr 8, 2026

Hsu Ming Tsan (Reporting)

Apr 1, 2026

Hsu Feng-Lin (Reporting)

Apr 1, 2026

Hsu Feng-Lin (Reporting)

Apr 1, 2026

Other

TYPE

HEADLINE

FILED AT